Download presentation
Presentation is loading. Please wait.
1
Volume 44, Issue 1, Pages 13-23 (February 2017)
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach Michele Boisdron-Celle, Olivier Capitain, Roger Faroux, Christophe Borg, Jean Philippe Metges, Marie Pierre Galais, Mehdi Kaassis, Jaafar Bennouna, Karine Bouhier-Leporrier, Eric Francois, Isabelle Baumgaertner, Véronique Guerin-Meyer, Oana Cojocarasu, Celia Roemer-Becuwe, Claire Stampfli, Ludovic Rosenfeld, Thierry Lecompte, Virginie Berger, Alain Morel, Erick Gamelin Seminars in Oncology Volume 44, Issue 1, Pages (February 2017) DOI: /j.seminoncol Copyright © 2017 Elsevier Inc. Terms and Conditions
2
Fig. 1 Metabolic pathways of 5-fluorouracil.
Seminars in Oncology , 13-23DOI: ( /j.seminoncol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
3
Fig. 2 Distribution of DPD enzyme activity in a healthy population. Distribution of DPD enzyme activity in the 132 caucasian individuals tested in this study. The distribution differs significantly from Gaussian Normal and has significant positive skew and kurtosis [7]. Seminars in Oncology , 13-23DOI: ( /j.seminoncol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
4
Fig. 3 Different SNPs in the hot spots of the DPYD gene. In red are shown the SNPs systematically screened in clinical practice. Seminars in Oncology , 13-23DOI: ( /j.seminoncol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
5
Fig. 4 Study design. Seminars in Oncology , 13-23DOI: ( /j.seminoncol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
6
Fig. 5 Survival probability of the two populations of patients without grade ≥3 toxic events (arm A: blue, arm B: red). Seminars in Oncology , 13-23DOI: ( /j.seminoncol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.